Parkinson's Disease

This hub offers a comprehensive exploration of Parkinson’s disease, integrating the latest scientific understanding, clinical practice, and emerging research. The linked articles cover the fundamentals of Parkinson’s disease pathophysiology, diagnosis, treatment strategies, and prognosis, while also examining associated conditions, genetic factors, and disease-modifying therapies. Readers will find evidence-based guidance on symptom management, including motor and non-motor features, along with in-depth discussions on neuroprotective interventions, the gut-brain axis, and the role of comorbidities. The collection also addresses the psychosocial impact of Parkinson’s disease, support resources, and advances in experimental therapies. Whether you are a healthcare professional, researcher, patient, or caregiver, these resources provide authoritative insights into the complex landscape of Parkinson’s disease.

Does Exercise Slow Parkinson's Disease Progression?

A growing pool of evidence suggests that high-intensity physical exercise may have beneficial outcomes in PD patients.

Progressive Supranuclear Palsy (PSP) Versus Parkinson's Disease

Neurophysiotherapy for Parkinson's Disease

Parkinsonism in Spinocerebellar Ataxia

Herpes Virus and Parkinson's Disease

Physiotherapy for Parkinson's Disease

Uncovering Hidden Symptoms: Hallucinations and Delusions in Parkinson’s Disease

Parkinson's Compared to Dementia with Lewy Bodies (DLB)

Gut Bacteria Affecting Parkinson’s Treatment

VPS35 Gene and Parkinson's Disease

Do Antioxidants Benefit Patients with Alzheimer’s and Parkinson’s?

Parkinson's Disease Diagnosis

See more featured articles »

Estrogen as a Treatment for Parkinson’s Disease

What is Parkinson's Disease?

Parkinson's Disease and Helicobacter Pylori

Parkinson's Disease Pathophysiology

Impact of COVID-19 on Parkinson's Disease

Parkinson's Disease Treatment

Human brain may stay active for hours after death

Developing Drugs for Neurodegenerative Diseases

Where Does Parkinson’s Disease Originate?

Thalamotomy, Pallidotomy and Subthalamotomy

Parkinson's Disease Prognosis

Parkinson's Disease Research

Is Appendectomy Linked to Parkinson’s Disease?

Bipolar Disorder and Parkinson’s

Parkinson's Disease History

Identifying Early Symptoms in Parkinson’s

Mythbusting: Misconceptions surrounding Parkinson’s Disease

Parkinson's Disease and the Gut Microbiome

Gut-Brain Axis and Neurodegenerative Disorders

Gene Therapies for Parkinson’s Disease

Parkinson's Disease Support

Parkinson’s Disease and Sleeping Disorders

Latest Parkinson's Disease News and Research

Astrocytes form complex networks across the mouse brain

Cells long thought to play a secondary role in brain function build their own far-reaching connections, a new study in mice showed. These pathways appear to connect distant regions in ways that have not been mapped before.

23 Apr 2026

Virtual neurology visits match in-person care outcomes

For people who see a neurology clinician for the first time, a new study has found that being seen virtually vs. in-person made no difference in how soon they needed more care.

22 Apr 2026

Study links cognitive worries in Parkinson’s to anxiety and depression

For many individuals living with Parkinson's disease and those in its "prodromal" or early stages before movement impairment, there is a distressing gap between how they feel their brain is working and what clinical tests show.

21 Apr 2026

Psychotropic medication use rises significantly after Parkinson's disease diagnosis

Up to one in three people with Parkinson's disease use at least one psychotropic medication, a recent study from the University of Eastern Finland shows.

21 Apr 2026

Gut microbiome analysis may help detect Parkinson’s before symptoms appear

Analysis of microbes in the gut can reveal whether a person faces an elevated risk of Parkinson's disease, before they have developed any symptoms, suggests a new study led by University College London (UCL) researchers.

20 Apr 2026

Antiretroviral therapy reduces biological aging in people living with HIV

A major study presented today at ESCMID Global 2026 has found that antiretroviral therapy (ART) reduces accelerated biological ageing in people with HIV (PWH) by nearly four years, a finding that could transform how clinicians monitor HIV treatment and long-term health outcomes.

20 Apr 2026

Barrow Neuro Analytics Center grows to advance neuroscience research

Barrow Neurological Institute has expanded its Barrow Neuro Analytics Center, nearly doubling its dedicated research space to more than 18,000 square feet and bringing additional research programs into one location.

9 Apr 2026

Fat-producing enzyme identified as key driver of damage in Parkinson’s disease

A fat-producing enzyme in brain cells may play a key role in driving damage in Parkinson's disease and could offer a new target for treatment, scientists at Nanyang Technological University, Singapore (NTU Singapore) have found.

9 Apr 2026

NIH funds AI project to advance Alzheimer’s research and treatment

The National Institutes of Health has renewed support for Artificial Intelligence for Alzheimer's Disease, or AI4AD. The new $12.6 million award to advance the project's next phase, AI4AD2, brings its total investment in AI4AD to $30.7 million.

1 Apr 2026

Small molecule may block protein buildup in neurodegenerative diseases

A team of researchers from NYU Abu Dhabi and the University of Denver have identified a promising small molecule that could help slow or halt the progression of serious brain diseases such as Parkinson's disease, offering new hope for treatments that go beyond managing symptoms.

1 Apr 2026

Timing of acetylcholine release determines if dopamine promotes movement or learning

Scientists have long-studied the role of dopamine, a chemical in the brain that helps control learning and movement, in order to better understand Parkinson's disease, schizophrenia, and depression-afflictions caused, in part, by a disruption or alteration of dopamine activity.

25 Mar 2026

Severe infections linked to higher dementia risk independent of coexisting illnesses

Severe infections increase the risk of dementia independently of other coexisting illnesses, according to a new study published March 24th in the open-access journal PLOS Medicine by Pyry Sipilä of the University of Helsinki, Finland, and colleagues.

24 Mar 2026

Walking patterns help distinguish Lewy body dementia from Parkinson’s

Doctors often struggle to distinguish early dementia with Lewy bodies from early Parkinson's disease.

24 Mar 2026

New nanoparticle system boosts scalable production of therapeutic exosomes

Researchers from Xi'an Jiaotong-Liverpool University (XJTLU) in China have developed a streamlined process that makes it easier to produce tiny therapeutic particles released by cells, called exosomes, which are being explored as a new type of medical treatment.

24 Mar 2026

Study identifies early risk factors for progressive supranuclear palsy

Progressive supranuclear palsy, or PSP, is a rare brain disease that causes problems with balance, eye movements and thinking. Civil rights leader Jesse Jackson recently passed away after living with the disease for more than a decade.

24 Mar 2026

New protein atlas identifies distinct subtypes of neurodegenerative diseases

Neurodegenerative diseases form a tangled biological web with overlapping molecular signatures and symptoms. To decode this complexity, a multi-institute collaboration led by St. Jude Children's Research Hospital scientists developed the pan-neurodegeneration atlas (PanNDA).

23 Mar 2026